NHS Cervical Screening Programme, England, 2011-12: Graphs.

Slides:



Advertisements
Similar presentations
NHS CERVICAL SCREENING PROGRAMME AND REFERRAL PATTERNS FOR COLPOSCOPY Dr Sue Calvert.
Advertisements

1.46 million women eligible for screening. 380,000 samples reported annually. East of England Region Cluster map: NHS East of England East of England Cancer.
NHS Breast Screening Programme, England : Graphs.
NHS Breast Screening Programme, England : Graphs.
1 Copyright © 2014, Health and Social Care Information Centre. All rights reserved Breast Screening Programme, England, Statistics for : Graphs.
1 Cervical Screening Programme, England, : Graphs.
Breast Screening Programme, England, Statistics for : Graphs
National Cancer Screening Programmes Bowel Screening Breast Screening Cervical Screening.
The Cytology Laboratory Chris Faraker Clinical Cytologist East Sussex Healthcare Trust.
The NHS Cervical Screening Programme
Cervical Screening and HPV testing
Sample Taker Training Cervical Cytology & Management of Abnormalities.
04/05/20041 Liquid Based Cytology Workshop. 04/05/20042 Programme content Session 1 : Overview of the cervical screening programme & why LBC has been.
The Role of the Cytology Laboratory
Cervical screening Tim Wright Sept 07. Introduction What who when What who when Benefits (evidence) Benefits (evidence) Cost Cost Does it fit wilson’s.
Key Information about CervicalCheck for Non-Medical Staff in Primary Care.
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Key Information About CervicalCheck for Non-medical Staff in Primary Care.
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
Can technology save the NHS? An alternative view Cleveland Henry, Delivery Director, NHS Choices 2 June 2015.
1 ANNUAL PUBLIC HEALTH REPORT 2011 Extending life in Islington Harriet Murrell Public Health Strategist. on behalf of Islington’s Public.
Overview of NHS Cervical Screening Programme Cervical Screening QARC Training School October 2012.
National Chlamydia Screening Programme Chlamydia testing and diagnoses in year olds, England January – December 2014 CTAD Team HIV & STI Department.
Cunliffeanalytics Cancer indicator trend analysis Stort Valley & Villages locality Summary of practice level cancer indicators 2010 to 2012 Version 2.1.
1 Cervical Screening Programme, England, : Graphs.
Participation by People with Multiple Sclerosis in Health Screening: a General Practice based Audit MacLurg K(1), Hawkins S (2), Reilly P(1) 1. Department.
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
1 Cervical Screening Programme, England, : Graphs.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Breast Screening Programme Statistics for , England: Graphs.
NHS Cervical Screening Programme, England, : Graphs.
HPV testing as a Primary screening tool in England Dr Karin Denton.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
NHS Cervical Screening Programme Introducing HPV triage and test of cure.
Quality and Outcomes Framework The national Quality and Outcomes Framework (QOF) was introduced as part of the new General Medical Services (GMS) contract.
National Guidance By Dr Keith Faulkner, Liz Henley & Caroline Burnley Implementation of HPV Triage and Test of Cure Workshop Friday 17 th June 2011.
CERVICAL CANCER SCREENING UPDATE Dr Keith Faulkner Quality Assurance Reference Centre NHS North East, Yorkshire and the Humber.
Prison Abnormalities Dr J H F Smith Royal Hallamshire Hospital, Sheffield East Pennine Cytology Training Centre NEYH Cervical Screening Symposium 2013.
Health & Social Care Information Centre SEPHIG: 12 th September, 2012.
Cervical cancer screening and treatment among HIV+ women in Cambodia: feasible and high yielding M.-E. Raguenaud 1, P. Isaakidis 1, S.A. Khim 1, C. Ping.
Understanding Test Results
Public Health England leads the NHS Screening Programmes
Breast Screening Programme
Breast Screening Programme, England, Statistics for : Graphs
NHS Cervical Screening Programme Introducing HPV Triage
Cytology Codes & management Colposcopy- Management of cervical lesions
Cervical Screening Programme, England, : Graphs
Bladder Cancer (C67): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 66.5% 63.6% patients treated for cancer.
NHS Cervical Screening Programme, England, : Graphs
Bone Cancer (C40-C41): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.4% 50.0% 51.7% patients treated for.
Breast Screening Programme, England, Statistics for : Graphs
Cervical Cancer (C53): 2014 Cancer Patient Experience Survey, by Sex, England Female Percentage of 62.9% patients treated for cancer who visited their.
NHS Cervical Screening Programme, England : Graphs
Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.
In Situ Breast Carcinoma: 2014
Breast Cancer (C50): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 87.5% 83.3% 87.4% patients treated for cancer.
Laryngeal Cancer (C32): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 47.1% 51.0% 50.3% patients treated for.
Stomach Cancer (C16): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 39.0% 51.7% 48.0% patients treated for cancer.
Public Health England leads the NHS Screening Programmes
Liver Cancer (C22): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 42.2% 57.1% 52.8% patients treated for cancer.
Ovarian Cancer (C56-C57.4): 2014 Cancer Patient Experience Survey, Females, England Female Percentage of 47.0% patients treated for cancer who visited.
Eye Cancer (C69): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 86.4% 76.6% 80.9% patients treated for cancer.
Kidney Cancer (C64-C66,C68): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 62.2% 59.2% patients treated.
Lung Cancer (C33-C34): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 50.3% 51.4% 50.9% patients treated for.
Prostate Cancer (C61): 2014 Cancer Patient Experience Survey, Males, England Male Percentage of 51.9% patients treated for cancer who visited their GP.
Myeloma (C90): 2014 Cancer Patient Experience Survey, by Sex, England
The National Cervical Screening Programme
Pancreatic Cancer (C25): 2014
Gallbladder Cancer (C23): 2014
Anal Cancer (C21): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 45.9% 60.8% 50.9% patients treated for cancer.
Presentation transcript:

NHS Cervical Screening Programme, England, : Graphs

© Data prior to 2005, re-used with the permission of the Department of Health. Source: KC53, Health and Social Care Information Centre. See also Tables 1 and 13 in Data Tables section. Figure 1: Cervical screening: Five year coverage of the target age group (25-64), England at 31 st March, 2002 to 2012

Source: KC53, Health and Social Care Information Centre. See also Table 13 in Data Tables section. Figure 2: Cervical screening: Age appropriate coverage by age, England, at 31 st March, 2011 and 2012

NB: Due to rounding, the figures presented in the above bar chart may not exactly match those derived from aggregating the relevant columns from Table 13 in the Data Tables section. Source: KC53, Health and Social Care Information Centre. See also Table 13 in Data Tables section. Figure 3 - Cervical screening: five year coverage of the target age group (25-64) by Primary Care Organisation (PCO), England, 31 st March 2012

NB: Due to rounding, the figures presented in the above map may not exactly match those derived from aggregating the relevant columns from Table 13 in the Data Tables section. Source: KC53, Health and Social Care Information Centre. See also Table 13 in Data Tables section. Figure 3a - Cervical screening: five year coverage of the target age group (25-64) by Primary Care Organisation, England, 31 st March 2012

Source: KC53, Health and Social Care Information Centre. See also Table 4 in Data Tables section. Figure 4: Number of women invited for screening by age group and year, to

Source: KC53, Health and Social Care Information Centre. See also Table 5 in Data Tables section. Figure 5: Number of women tested by year and age group, to

* This chart is shown to 2 decimal places due to the very small percentages involved. Note that the percentages in Figure 6 are aggregates of 3 test result groups (severe dyskaryosis, severe dyskaryosis/?invasive carcinoma and ?glandular neoplasia). The aggregated figures shown in Figure 6 may not equal the sum of the individual components shown in Table 8 in the Data Tables due to rounding. Source: KC53, Health and Social Care Information Centre. See also Table 8 in Data Tables section. Figure 6* – Cervical screening: women with test result severe dyskaryosis or worse as a percentage of all women with adequate test results, by age, England

NB: The percentages in Figure 7 are aggregates of 4 test result groups (borderline changes, mild dyskaryosis, moderate dyskaryosis and severe dyskaryosis or worse). The aggregated figures shown in Figure 7 may not equal the sum of the individual components shown in Table 12 in the Data Tables due to rounding. Source: KC53, Health and Social Care Information Centre. See also Table 12 in Data Tables section. Figure 7 - Cervical screening: Percentage of tests for women aged 25-64, with an abnormal result by Primary Care Organisation (PCO), England

Source: National Cancer Screening Statistics VSA15 Report, Connecting for Health (CfH) ‘Open Exeter’ system (NHAIS). See also Tables 9 and 9a in Data Tables section. Figure 8: Cervical Screening: Time from screening to receipt of results as measured by expected date of delivery of result letter by Strategic Health Authority (eligible women aged 25 – 64 years), percentage received within 2 weeks, and

© Data prior to 2005, re-used with the permission of the Department of Health. Source: KC61, Health and Social Care Information Centre. See also Table 15 in Data Tables section. Figure 9 - Cervical cytology: Percentages of samples from GP & NHS Community Clinics found to be inadequate, from women of all ages, England to

NB: Due to rounding, the figures presented in the above bar chart may not exactly match those derived from aggregating the relevant columns from Table 19 in the Data Tables section. Source: KC61, Health and Social Care Information Centre. See also Tables 19 in Data Tables section. Figure 10 - Cervical cytology: Percentage of samples from GP & NHS Community Clinics found to be inadequate, for women aged 25-64, by laboratory, England

Source: KC61, Health and Social Care Information Centre. See also Table 18a in Data Tables section. Figure 11 - Outcome of referral, following persistent non-negative test result, England, April June 2011

NB: The sum of components may not equal totals due to rounding. Source: KC61, Health and Social Care Information Centre. See also Table 18a in Data Tables section. Figure 12 - Outcome of referral, following single occurrence of potentially significant abnormality, England, April June 2012

Source: KC61, Health and Social Care Information Centre. See also Table 19 in Data Tables section. Figure 13 - Positive Predictive Value, by laboratory, England, April June 2011

Source: KC65, Health and Social Care Information Centre. See also Table 21 in Data Tables section. Figure 14 - Women referred to colposcopy: time from referral to first offered appointment by indication,

NB: The sum of components may not equal totals due to rounding. Source: KC65, Health and Social Care Information Centre. See also Table 24 in Data Tables section. Figure 15: Biopsies taken at colposcopy: time from biopsy until patient informed of result (4 month sample),